Curigliano G, Shapiro GI, Kristeleit RS, Abdul Razak AR, et al. Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. Br J Cancer 2023 Jan 25. doi: 10.1038/s41416-023-02161.
PMID: 36697966